Ovarian germ cell tumor diagnostic study of choice: Difference between revisions
Created page with "__NOTOC__ {{Ovarian germ cell tumor}} {{CMG}}; {{AE}} == Overview == == Diagnostic Study of Choice == === Study of choice === [Name of the investigation] is the gold standar..." |
No edit summary |
||
(6 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ovarian germ cell tumor}} | {{Ovarian germ cell tumor}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Sahar}} {{MD}} | ||
== Overview == | == Overview == | ||
[[Histology]] of the excised [[tumor]] after [[surgery]] is the [[Gold standard (test)|gold standard]] test for the [[diagnosis]] of [[ovarian]] [[germ cell]] [[Tumor|tumors]]. [[Surgery]] must be performed when the patient presents with an [[adnexal]] [[mass]] in the [[abdominal]]/[[pelvic]] [[Physical examination|exam]] and elevated serum concentration of associated [[tumor markers]]. [[Mature cystic teratoma|Mature teratoma]] may be [[Diagnosis|diagnosed]] using [[Ultrasound|ultrasonographic imaging]]. However, the [[tumor]] should be removed [[Surgery|surgically]]. | |||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
[[Histology]] of the excised [[tumor]] after [[surgery]] is the [[Gold standard (test)|gold standard]] test for the [[diagnosis]] of [[ovarian]] [[germ cell]] [[tumors]].<ref name="PectasidesPectasides2008">{{cite journal|last1=Pectasides|first1=D.|last2=Pectasides|first2=E.|last3=Kassanos|first3=D.|title=Germ cell tumors of the ovary|journal=Cancer Treatment Reviews|volume=34|issue=5|year=2008|pages=427–441|issn=03057372|doi=10.1016/j.ctrv.2008.02.002}}</ref><ref name="LowIlancheran2012">{{cite journal|last1=Low|first1=Jeffrey J.H.|last2=Ilancheran|first2=Arunachalam|last3=Ng|first3=Joseph S.|title=Malignant ovarian germ-cell tumours|journal=Best Practice & Research Clinical Obstetrics & Gynaecology|volume=26|issue=3|year=2012|pages=347–355|issn=15216934|doi=10.1016/j.bpobgyn.2012.01.002}}</ref> | |||
* [[Surgery]] must be performed when: | |||
** The patient presents with an [[adnexal]] [[mass]] in the [[abdominal]]/[[pelvic]] exam, and elevated serum concentration of [[Human chorionic gonadotropin|hCG]], [[Lactate dehydrogenase|LDH]], [[AFP]], and other associated [[tumor markers]]. | |||
** [[Mature cystic teratoma|Mature teratoma]] may be [[Diagnose|diagnosed]] using [[Ultrasound imaging|ultrasonographic imaging]]. However, the [[tumor]] should be removed [[Surgery|surgically]]. | |||
{{familytree/start |summary=PE diagnosis Algorithm.}} | |||
{{familytree | | | | | | | | | | A02 | | | | | |A02=[[Malignant]] [[germ cell]] [[tumor]]}} | |||
{{familytree | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | }} | |||
{{familytree | | | C01 | | | | | | | | | | | | | C02 | | |C01=Prior [[surgery]]|C02=Initial [[surgery]]}} | |||
{{familytree | |,|-|^|-|.| | | | | | | | | | |,|-|^|-|.| | }} | |||
{{familytree | D01 | | D02 | | | | | | | | | D03 | | D04 |D01=Complete staging|D02=Incomplete staging|D03=[[Fertility]] sparing prefered|D04=[[Fertility]] sparing not prefered}} | |||
{{familytree | |!| | | |!| | | | | | | | | | |!| | | |!| | }} | |||
{{familytree | E01 | | E02 | | | | | | | | | E03 | | E04 |E01=Treatment based<br>on<br>the staging|E02=[[Imaging]]:<br>[[Chest]]/<br>[[abdomen]]/<br>[[pelvis]] [[CT]] with [[contrast]]|E03=[[Fertility]] sparing [[surgery]]<br>and<br>complete staging|E04=[[Surgery]] to stage}} | |||
{{familytree | | | | | |!| | | | | | | | | | |!| | | |!| | | | }} | |||
{{familytree | | | | | |!| | | | | | | | | | |`| F02 |'| | | |F02=Treatment based on the staging and [[pathology]] of [[tumor]]}} | |||
{{familytree | | | |,|-|^|-|-|-|-|-|-|-|.| | | | | | | }} | |||
{{familytree | | | G01 | | | | | | | | G02 | | | | | | | | | | | | | | |G01=[[Yolk sac tumor]]<br>grade2-3 immature [[teratoma]],<br>non-gestational [[choriocarcinoma]]<br>or mixed [[histology]]|G02=[[Dysgerminoma]]<br>or<br>grade 1 immature [[teratoma]]|L03=[[Dysgerminoma]] or grade 1 immature [[teratoma]]}} | |||
{{familytree | | | |!| | | | | | | | | |!| | | | | | | | | | | | }} | |||
{{familytree | | | |!| | | | | |,|-|-|-|+|-|-|-|.|}} | |||
{{familytree | | | |!| | | | | I02 | | I03 | | I04 | |I02=[[Imaging]] and [[tumor markers]]<br>are<br>positive|I03=Negative [[imaging]]<br>and<br>positive [[tumor markers]]|I04=Negative [[imaging]]<br>and<br>negative or positive [[tumor markers]]}} | |||
{{familytree | | | |!| | | | | |!| | | |!| | | |!| | | |}} | |||
{{familytree | |,|-|^|-|.| | | K03 | | K04 | | K05 | | |K03=Decide according to [[fertility]] sparing preference<br>and/or [[pathologic]] finding<br>for [[surgery]] and<br>further [[adjuant therapy]]|K04=Observe|K05=Observe|}} | |||
{{familytree | J01 | | J02 | | | | | | | | | | | | | | | | | | |J01=[[Imaging]] and [[tumor markers]]<br>are<br>positive|J02=Negative [[imaging]]<br>and<br>negative and positive [[tumor markers]]}} | |||
{{familytree | |!| | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | K01 | | | | | | | | | | | | | | | | | | | |K01=Decide<br>according to<br>[[fertility]] sparing preference<br>for [[surgery]] and further [[chemotherapy]]|}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree/end}} | |||
==References== | ==References== | ||
Line 130: | Line 40: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | |||
[[Category:Types of cancer]] | |||
[[Category:Gynecology]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gynecology]] | |||
[[Category:Surgery]] |
Latest revision as of 13:51, 22 April 2019
Ovarian germ cell tumor Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ovarian germ cell tumor diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Ovarian germ cell tumor diagnostic study of choice |
Ovarian germ cell tumor diagnostic study of choice in the news |
Risk calculators and risk factors for Ovarian germ cell tumor diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Monalisa Dmello, M.B,B.S., M.D. [3]
Overview
Histology of the excised tumor after surgery is the gold standard test for the diagnosis of ovarian germ cell tumors. Surgery must be performed when the patient presents with an adnexal mass in the abdominal/pelvic exam and elevated serum concentration of associated tumor markers. Mature teratoma may be diagnosed using ultrasonographic imaging. However, the tumor should be removed surgically.
Diagnostic Study of Choice
Histology of the excised tumor after surgery is the gold standard test for the diagnosis of ovarian germ cell tumors.[1][2]
- Surgery must be performed when:
- The patient presents with an adnexal mass in the abdominal/pelvic exam, and elevated serum concentration of hCG, LDH, AFP, and other associated tumor markers.
- Mature teratoma may be diagnosed using ultrasonographic imaging. However, the tumor should be removed surgically.
Malignant germ cell tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prior surgery | Initial surgery | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Complete staging | Incomplete staging | Fertility sparing prefered | Fertility sparing not prefered | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment based on the staging | Imaging: Chest/ abdomen/ pelvis CT with contrast | Fertility sparing surgery and complete staging | Surgery to stage | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment based on the staging and pathology of tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yolk sac tumor grade2-3 immature teratoma, non-gestational choriocarcinoma or mixed histology | Dysgerminoma or grade 1 immature teratoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Imaging and tumor markers are positive | Negative imaging and positive tumor markers | Negative imaging and negative or positive tumor markers | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Decide according to fertility sparing preference and/or pathologic finding for surgery and further adjuant therapy | Observe | Observe | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Imaging and tumor markers are positive | Negative imaging and negative and positive tumor markers | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Decide according to fertility sparing preference for surgery and further chemotherapy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Pectasides, D.; Pectasides, E.; Kassanos, D. (2008). "Germ cell tumors of the ovary". Cancer Treatment Reviews. 34 (5): 427–441. doi:10.1016/j.ctrv.2008.02.002. ISSN 0305-7372.
- ↑ Low, Jeffrey J.H.; Ilancheran, Arunachalam; Ng, Joseph S. (2012). "Malignant ovarian germ-cell tumours". Best Practice & Research Clinical Obstetrics & Gynaecology. 26 (3): 347–355. doi:10.1016/j.bpobgyn.2012.01.002. ISSN 1521-6934.